Liveraid capsule
Item requires a valid prescription
Manufactured By : Pharmed Ltd
Rs 342.00
MRP Rs 380.00
(10% OFF)
Includes all taxes
Package SIZE
( strip of 15 capsules )
100% Authentic
Products
Free
Shipping*
Product
Returnable
Liveraid Capsule is a unique combination of Silymarin, Alpha lipoic acid, Selenium and L-ornithine-L-aspartate (LOLA).
Silymarin is used to regenerate liver cells damaged by alcohol or drugs, decongest the liver. A liver decongestant stimulates bile flow through the liver and gallbladder, thus reducing stagnation and preventing gallstone formation and bile-induced liver damage, increase the survival rate of patients with cirrhosis, complement the treatment of viral hepatitis, protect against industrial poisons.
L-ornithine-L-aspartate (LOLA) improves the ability of the liver and other organs to detoxify ammonia and hence is useful in patients with liver cirrhosis and hepatic encephalopathy.
Alpha-lipoic acid is an antioxidant shown to decrease the amount of hepatic fibrosis associated with liver injury. This mechanism suggests it has promise for cirrhosis. Because alpha-lipoic acid is fat soluble, it can penetrate the cell membrane to exert therapeutic action.
Use under medical supervision.
- Uses / Indications: Liveraid Capsule is a unique combination of Silymarin, Alpha lipoic acid, Selenium and L-ornithine-L-aspartate (LOLA). Silymarin is used to regenerate liver cells damaged by alcohol or drugs, decongest the liver. A liver decongestant stimulates bile flow through the liver and gallbladder, thus reducing stagnation and preventing gallstone formation and bile-induced liver damage, increase the survival rate of patients with cirrhosis, complement the treatment of viral hepatitis, protect against industrial poisons. L-ornithine-L-aspartate (LOLA) improves the ability of the liver and other organs to detoxify ammonia and hence is useful in patients with liver cirrhosis and hepatic encephalopathy. Alpha-lipoic acid is an antioxidant shown to decrease the amount of hepatic fibrosis associated with liver injury. This mechanism suggests it has promise for cirrhosis. Because alpha-lipoic acid is fat soluble, it can penetrate the cell membrane to exert therapeutic action. Use under medical supervision.
